ロード中...
Estradiol as a Targeted, Late-Line Therapy in Metastatic Breast Cancer with Estrogen Receptor Amplification
Estradiol is a major regulator of growth for the subset of breast cancers that express the estrogen receptor (ER, ESR1). Strategies to block ER action, via reduction of estradiol or direct inhibition of ER, have shown major success in the prevention and treatment of breast cancer. However, most ER-p...
保存先:
| 出版年: | Cureus |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cureus
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5587405/ https://ncbi.nlm.nih.gov/pubmed/28924522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1434 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|